ENGLEWOOD, Fla., Aug. 30, 2005 (PRIMEZONE) -- SinoFresh HealthCare, Inc. (OTCBB:SFSH) today announced it has retained business development firm CAM-Global, Irvine, CA, to help direct its entry into global licensing and distribution arrangements for its broad-spectrum antiseptic technology. The SinoFresh technology is chiefly applicable to upper respiratory therapies that target bacterial, fungal, and viral-source diseases affecting hundreds of millions of people worldwide.
CAM-Global's efforts will focus on assessing and quantifying the value of the SinoFresh technology and intellectual property in various world markets. It will also assist in collecting and evaluating the many inquiries SinoFresh has received from interested parties both domestically and internationally.
Michael Geranen, CAM-Global Managing Director, stated, "This is a tremendously exciting assignment given the late stage clinical program and the technology's ability to bring better patient care to allergic and non-allergic rhinitis sufferers."
"People are beginning to realize that SinoFresh HealthCare is much more than over-the-counter nasal sprays and throat sprays," explained Chairman and CEO Charles Fust. "The science behind our products is compelling, innovative, and increasingly pointing to new treatments for an array of complex upper respiratory ailments. I am encouraged by the interest surfacing from pharmaceutical organizations in virtually every corner of the globe."
About CAM-Global
CAM-Global is a global business development firm specializing in assisting companies to better evaluate and seize upon worldwide opportunities for growth and expansion. More information is available at www.cam-global.com, or please contact Michael Geranen, Managing Director, mbg@cam-global.com.
About SinoFresh HealthCare, Inc.
SinoFresh HealthCare, Inc. is a developer and marketer of innovative therapies for conditions of the upper respiratory system. The Company is researching broad-spectrum antiseptic approaches to reducing viral, bacterial, and fungal organisms that are suspected to cause pathogenesis of the mouth, nose, and throat. The Company's lead product, SinoFresh(tm) Nasal Spray, is a hygienic cleansing spray that kills germs and removes other nasal-sinus irritants. SinoFresh(tm) Nasal Spray is available nationwide in Wal-Mart, Walgreens, Rite Aid, CVS, and other drug, grocery and mass merchandise retailers. More information is available at www.sinofresh.com.
Except for the historical information contained herein, this press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any forward-looking statements speak only as of the date on which such statements are made and involve risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission, including risks summarized in the Company's Annual Report on Form 10-KSB for its fiscal year ended December 31, 2004 (file No. 0-49764). The Company's actual results could differ materially from such forward-looking statements. The Company undertakes no obligation to update any forward-looking statement or statements to reflect new events or circumstances or future developments.
SinoFresh(tm) is a trademark of SinoFresh HealthCare, Inc.